Journal article
Economic burden of patients with leading cancers in China: a cost-of-illness study
Abstract
BackgroundChina accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. Comprehensive analyses of the economic burden on patients across different cancer treatment phases, based on empirical data, are lacking. This study aims to estimate the financial burden borne by patients and analyze the cost compositions of the leading cancers with the highest number of new cases in China.MethodsThis cross-sectional …
Authors
Wu Z; Yu Y; Xie F; Chen Q; Cao Z; Chen S; Liu GG
Journal
BMC Health Services Research, Vol. 24, No. 1,
Publisher
Springer Nature
DOI
10.1186/s12913-024-11514-x
ISSN
1472-6963